Conversely, a study in non-human primates found that established dyskinesia could be reversed by chronic inhibition of striatal ERK1/2 signaling using virally expressed dominant negative mutants of Ras-GRF and ERK275, indicating that ERK1/2 signaling does play an important role in maintaining established LID. The gene discussed is GHRH; the disease is drug-induced dyskinesia.